TRANSPAPNEO: Skin-to-skin Contact During the Transfer From the Delivery Room to the Neonatal Intensive Care Unit: Impact on Very Preterm Infants and Their Parents

Sponsor
University Hospital, Tours (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05820386
Collaborator
(none)
118
4
2
27
29.5
1.1

Study Details

Study Description

Brief Summary

Developmental care are recognized as a standard of care for preterm infants in neonatal intensive care units. Regular skin-to skin contacts during the neonatal stay show short and long-term beneficial effects on preterm infants and their parents. Skin-to-skin contact provides hemodynamic and thermal stability in preterm infants. Regarding parents, skin-to-skin contact sustains the parental bonding, and reduces stress and anxiety related to hospitalization. As a result, early skin-to-skin contact has been associated with an improvement of neurological outcome in very preterm infants.

Thermal stability is crucial during the first hour of life in preterm infants. A temperature at admission in the neonatal intensive care unit below 36.5°C or above 37.2°C has been associated with an increase in neonatal morbidity and mortality.

Early skin-to-skin contact between a newborn and his/her mother in the delivery room significantly decreases the occurrence of hypothermia below 35.5°C.

The practice of skin-to-skin transfer from the delivery room is emerging in France. Pilot studies have been carried out by French neonatal teams that showed the feasibility of this practice in late-preterm, near-term and term infants. Although skin-to-skin contact routinely involves very preterm infants in neonatal intensive care units worldwide, the feasibility and safety of skin-to-skin contact during the transfer from delivery room to the neonatal unit is poorly documented in very preterm infants. Previous data of our team showed that transfer of preterm infants with non-invasive ventilation using skin-to-skin contact was feasible and safe but concerns emerged about the thermal conservation during the procedure.

The main hypothesis of this study is that skin-to skin contact during the transfer from the delivery room to the neonatal intensive care unit could prevent heat losses in preterm infants as well as the transfer in incubator. Another hypothesis is that very early skin-to-skin contact could positively influence the neonatal course and the parental experience in the neonatal care unit.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Skin-to-skin Contact (SSC)
  • Procedure: Incubator
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
118 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Assessment of Skin-to-skin Contact During the Transfer of Very Preterm Infants From the Delivery Room to the Neonatal Intensive Care Unit : a Randomised Controlled, Non-inferiority, Open-label Trial, in Comparison With Transfer in Incubator
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
May 1, 2025
Anticipated Study Completion Date :
Aug 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Skin-to-skin contact during the transfer between the delivery room and the neonatal care unit

Preterm infants will be transferred using a direct skin-to-skin contact with their father from the delivery room to the intensive neonatal care.

Procedure: Skin-to-skin Contact (SSC)
For the Skin-to-skin Contact (SSC) transfer, the bare-chested father will seat in a wheelchair. Newborns who will wear only a diaper and a cotton cap or noninvasive ventilation headgear will be placed in the kangaroo position against the father's chest to ensure direct contact with the father's skin. Preterm infants with gestational age less than 33 weeks will be wrapped with their father using plastic bags plus warmed cotton towels. More gestationally mature infants will be wrapped with only warmed cotton wraps. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure.

Active Comparator: Transfer in incubator between the delivery room and the neonatal care unit

Preterm infants will be transferred in an incubator set to 36°C from the delivery room to the intensive neonatal care.

Procedure: Incubator
In the incubator group, infants will be transferred after resuscitation in an incubator with air temperature set to 36°C. The newborn will be laid on his/her back in a polyethylene bag with a cap. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure.

Outcome Measures

Primary Outcome Measures

  1. Change in the infant skin temperature due to the transfer procedure [During the transfer procedure]

    Fluctuation in the infant skin temperature between the randomization in the delivery room and the admission in the neonatal intensive care unit (NICU)

Secondary Outcome Measures

  1. Change in the infant's heart rate during the transfer procedure [During the transfer procedure]

    Heart rate values during the transfer procedure

  2. Occurrence of bradycardia episodes in infant during the transfer procedure [During the transfer procedure]

    Rapid decrease in heart rate less than 100 beats/min that lasts at least 10 secondes during the transfer procedure

  3. Change in the infant's oxygen saturation during the transfer procedure [During the transfer procedure]

    Oxygen saturation values during the transfer procedure

  4. Occurrence of desaturation episodes in infant during the transfer procedure [During the transfer procedure]

    Decrease in oxygen saturation less than 85% that last at least 10 secondes

  5. Change in the infant's fraction of inspired oxygen during the transfer procedure [During the transfer procedure]

    Fraction of inspired oxygen values during the transfer procedure

  6. Duration of the transfer procedure [During the transfer procedure]

    Time (in min) during the transfer procedure

  7. First Hydrogen Potential (pH) of the newborn [First blood gas in the NICU]

    First assessment of pH in the neonatal intensive care unit (NICU)

  8. Carbon dioxide partial pressure (pCO2) of the newborn [First blood gas in the NICU]

    First assessment of carbon dioxide partial pressure (pCO2) in the neonatal intensive care unit (NICU)

  9. Blood glucose of the newborn [First blood glucose measurement in the NICU]

    First assessment of blood glucose in the neonatal intensive care unit (NICU)

  10. Occurence of hypothermia [From admission in the neonatal intensive care unit to 30 min later]

    Decrease of skin temperature less than 36°C

  11. Time to the first skin-to-skin contact in the neonatal care unit [Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit]

    Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit

  12. Practice of skin-to-skin contact in the neonatal intensive care unit (NICU) during the first week of life [During the first 7 days of the stay in the neonatal care unit]

    Frequency of skin-to-skin contact (Postnatal day and hour), length of each skin-to-skin contact, which parent involves in each skin-to-skin contact episode.

  13. Quality of parental bond [2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30]

    Assessment through a maternal questionnaire: Mother-to-Infant Bonding Scale (MIBS) questionnaire (Mother-to-infant bonding scale - Taylor, 2005). Only the infant's mother will be invited to fill out this questionnaire.

  14. Parental stress [2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30]

    Parental stress assessed by Perceived Stress Scale (PSS) - Neonatal Intensive Care Unit (NICU) questionnaire (Perceived Stress Scale Neonatal Intensive Care Unit - Miles, 1993). The infant's mother and father will be invited to fill out this questionnaire.

  15. Parental post-traumatic stress disorder [At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30]

    Parental post-traumatic stress disorder assessed by Perinatal Post traumatic stress disorder Questionnaire (PPQ) - DEMIER, 1996). The infant's mother and father will be invited to fill out this questionnaire.

  16. Infant growth: Weight [At birth and weight at the postmenstrual age of 36 weeks]

    Weight at birth and at the postmenstrual age of 36 weeks

  17. Infant growth: Height [At birth and at the postmenstrual age of 36 weeks]

    Height at birth and at the postmenstrual age of 36 weeks

  18. Infant growth: Head circumference [At birth and at the postmenstrual age of 36 weeks]

    Head circumference at birth and at the postmenstrual age of 36 weeks

  19. Neonatal morbidity and mortality at the postmenstrual age of 36 weeks [At the postmenstrual age of 36 weeks]

    Death Intraventricular hemorrhage (maximal grade), Periventricular leukomalacia, Necrotizing enterocolitis (> stade 2 of the Bell classification), Neonatal surgery, Early onset sepsis (onset before postnatal day 2 and > 3 days of intravenous antibiotherapy), Late onset sepsis (Blood culture positive, number of events), Number of red blood cell transfusions, Duration of mechanical ventilation (days). Severe bronchopulmonary dysplasia, Retinopathy of prematurity that requires laser photocoagulation or intravitreal injection of proangiogenic factor, Length of stay in neonatal intensive care unit (days).

  20. Modalities of breastfeeding [During the NICU stay: infant postnatal day]

    First breastfeeding attempt in the neonatal intensive care unit (NICU)

  21. Modalities of breastfeeding [At the postmenstrual age of 36 weeks]

    Presence of complete or partial breastfeeding at the postmenstrual age of 36 weeks

  22. Mode of infant feeding at the postmenstrual age of 36 weeks [At the postmenstrual age of 36 weeks]

    Modes of infant feeding that include breastfeeding, breastmilk given through a bottle, artificial formula

Other Outcome Measures

  1. Self-questionnaires to study parents' experience of their infant hospitalization [2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30]

    Ancillary study: Self-questionnaires to study parents' experience of their infant hospitalization to assess stress at different times.

Eligibility Criteria

Criteria

Ages Eligible for Study:
24 Weeks to 34 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Gestational age < 34 weeks

  • Singleton pregnancy

  • Inborn birth, i.e., in the maternity ward of investigating centres

  • Need of hospitalization in the neonatal intensive care unit

  • Oral and written information of parents and written parental consent to participate in the study (by the father if the mother is unable to participate)

Exclusion Criteria:
  • Single parent or homosexual couple

  • Absence of the father in the delivery room

  • Parents not speaking French

  • Skin temperature of the newborn < 36°C at the time of randomization

  • Conditions not allowing the early skin-to-skin contact: omphalocele, gastroschisis, desquamating dermatological conditions (Harlequin syndrome, Collodion)

  • Clinical condition requiring a specific transfer mode according to the pediatrician in the delivery room

  • Parents under legal protection

  • Minor parents

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neonatal medicine and intensive care unit, University Hospital, Orléans Orléans France 45000
2 Neonatal intensive care unit, University Hospital, Saint-Etienne Saint-Étienne France 42055
3 Neonatology service, University Hospital, Toulouse Toulouse France 31300
4 Neonatal and paediatric service, University Hospital, Tours Tours France 37000

Sponsors and Collaborators

  • University Hospital, Tours

Investigators

  • Study Director: Nolwenn CLENET, University Hospital, Tours

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Tours
ClinicalTrials.gov Identifier:
NCT05820386
Other Study ID Numbers:
  • DR210297
First Posted:
Apr 19, 2023
Last Update Posted:
Apr 19, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Tours
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 19, 2023